Canadian Online Pharmacy

CDER New May 29, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

May 28, 2014


New and Generic Drug Approvals

May 27, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Aloxi palonosetron hydrochloride Injectable;Intravenous Helsinn Hlthcare Efficacy Supplement with Clinical Data to Support
Atovaquone and Proguanil Hydrochloride atovaquone; proguanil hydrochloride Tablet;Oral Mylan Pharms Inc Approval
Diclofenac Sodium diclofenac sodium Solution;Topical Apotex Inc Approval
Nikki drospirenone;ethinyl estradiol Tablet;Oral Lupin Ltd Approval
Pancreaze pancrelipase (amylase;lipase;protease) Capsule, Delayed Release;Oral Janssen Pharms Manufacturing Change or Addition
Phoslo calcium acetate Capsule;Oral Fresenius Medcl Manufacturing Change or Addition
Phoslo Gelcaps calcium acetate Capsule;Oral Fresenius Medcl Manufacturing Change or Addition
Synthroid levothyroxine sodium Tablet;Oral Abbvie Manufacturing Change or Addition
Valganciclovir valganciclovir Tablet;Oral Dr Reddys Labs Ltd Tentative Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery